A detailed history of Cresset Asset Management, LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 96,987 shares of MRVI stock, worth $545,066. This represents 0.0% of its overall portfolio holdings.

Number of Shares
96,987
Previous 22,937 322.84%
Holding current value
$545,066
Previous $164,000 390.85%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.84 - $9.73 $506,502 - $720,506
74,050 Added 322.84%
96,987 $805,000
Q2 2024

Aug 14, 2024

BUY
$6.87 - $11.34 $6,698 - $11,056
975 Added 4.44%
22,937 $164,000
Q1 2024

May 15, 2024

BUY
$5.11 - $8.76 $13,725 - $23,529
2,686 Added 13.93%
21,962 $190,000
Q4 2023

Feb 14, 2024

BUY
$4.7 - $9.87 $90,597 - $190,254
19,276 New
19,276 $126,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $739M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.